Frequently Asked Questions:
The global orthopedic splints and casts market was valued at USD 2.5 Billion in 2022.
The orthopedic splints and casts market is anticipated to grow at a CAGR of 6.2% between 2023 and 2030, reaching USD 3.8 Billion in 2030.
Casts is the leading segment by product, holding over 52% share in terms of value in 2022.
The synthetic splints & casts segment governs the demand for orthopedic splints and casts worldwide, holding a massive share of over 68% in 2022.
The upper body segment will post the highest CAGR over the forecast period.
Asia Pacific is fuelling the rapid growth of the orthopedic splints and casts industry, with an over one-third share in 2022.
The top players include DJO Global, Thuasne Group, AliMed Inc, and Vissco Rehabilitation. Other major players include Prime Medical Inc, Bird & Cronin, Elite Orthopaedics, and Trulife Healthcare.
The increasing prevalence of orthopedic injuries and musculoskeletal diseases, developments in lightweight and durable materials, technical innovations, and increased need for effective immobilization and support devices are the primary market drivers of the orthopedic splints and casts industry.
The major market restraints of the orthopedic splints and casts industry are the risk of complications such as skin irritation and pressure sores, limitations in range of motion and discomfort experienced by patients, the need for skilled healthcare professionals for proper application and removal, high costs of advanced splints and casts, and regulatory requirements for manufacturing orthopedic devices.
The expanding elderly population driving the need for orthopedic solutions, advancements in telemedicine and remote monitoring for orthopedic care, and emerging markets with increasing healthcare expenditure and infrastructure development are the major market opportunities for the orthopedic splints and casts industry.